Teva Pharmaceutical Industries Ltd.

Regulatory Filings • Feb 12, 2024

Form 10-K � ��"��� ������ ���� 2023 false

��� ������ ��������� ��"�	2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954	13365
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	12/02/2024
	www.isa.gov.il			www.tase.co.il				Reference:	2024-02-015465	Time of broadcast: 14:05 14:05

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onForm 10-K � ��"��� ������ ���� 2023

2023_Form_10K_isa.pdf

For an accessible version of this Form 10-K please visit www.tevapharm.com
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE	Date of revision of form structure: 31/12/2023
Address: Dvora Hanevi'a 124 , Tel Aviv 6944020   , Tel: 03-9148262 , Fax: 03-9267519
E-mail address: Yael.Ashman@teva.co.il
Previous names of reporting entity:
Name of the Signatory: Kalif Eli Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Dvira Hanevia 124 , Tel Aviv 6944020 Telephone: 03-9148262 Facsimile: E-mail: yael.ashman@teva.co.il 1